Skip to content

Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium

C19H23FN3O4+ — CID 9349371

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium
SMILESCC[NH+](Cc1ccc(OC)c(F)c1)[C@@H](C)C(=O)Nc1ccccc1[N+](=O)[O-]
InChIInChI=1S/C19H22FN3O4/c1-4-22(12-14-9-10-18(27-3)15(20)11-14)13(2)19(24)21-16-7-5-6-8-17(16)23(25)26/h5-11,13H,4,12H2,1-3H3,(H,21,24)/p+1/t13-/m0/s1
InChIKeyQDPZFZKSKJFIOX-ZDUSSCGKSA-O
MW376.41 g/mol
LogP2.17
Rot. Bonds8

About Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium

Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium (PubChem CID 9349371) has the molecular formula C19H23FN3O4+ and a molecular weight of 376.41 g/mol. Its IUPAC name is ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium.

Molecular Properties

Compound NameEthyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium
PubChem CID9349371
Molecular FormulaC19H23FN3O4+
Molecular Weight376.41 g/mol
Exact Mass376.17
IUPAC Nameethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium
SMILESCC[NH+](Cc1ccc(OC)c(F)c1)[C@@H](C)C(=O)Nc1ccccc1[N+](=O)[O-]
InChIInChI=1S/C19H22FN3O4/c1-4-22(12-14-9-10-18(27-3)15(20)11-14)13(2)19(24)21-16-7-5-6-8-17(16)23(25)26/h5-11,13H,4,12H2,1-3H3,(H,21,24)/p+1/t13-/m0/s1
InChIKeyQDPZFZKSKJFIOX-ZDUSSCGKSA-O
XLogP2.17
TPSA85.91 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500376.41
LogP ≤ 52.17
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium?
The IUPAC name of Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium (CID 9349371) is ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium.
What is the SMILES notation for Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium?
The canonical SMILES for Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium is CC[NH+](Cc1ccc(OC)c(F)c1)[C@@H](C)C(=O)Nc1ccccc1[N+](=O)[O-].
What is the InChIKey of Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium?
The InChIKey is QDPZFZKSKJFIOX-ZDUSSCGKSA-O. The full InChI is InChI=1S/C19H22FN3O4/c1-4-22(12-14-9-10-18(27-3)15(20)11-14)13(2)19(24)21-16-7-5-6-8-17(16)23(25)26/h5-11,13H,4,12H2,1-3H3,(H,21,24)/p+1/t13-/m0/s1.
What are the key properties of Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium?
Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium has a molecular weight of 376.41 g/mol, XLogP of 2.17, 8 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for Ethyl-[(3-fluoro-4-methoxyphenyl)methyl]-[(2S)-1-(2-nitroanilino)-1-oxopropan-2-yl]azanium is sourced from PubChem (CID 9349371), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.